NH
Therapeutic Areas
Zelluna Immunotherapy Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Proprietary TCR-NK Platform | Undisclosed Solid Tumors | Preclinical |
Leadership Team at Zelluna Immunotherapy
GC
Geir Christian Melen
Chief Financial Officer
AH
Anders Holm
Chief Operating Officer & Head of Business Development
LW
Luise Weigand
Chief Scientific Officer
EG
Emilie Gauthy
Chief Technology Officer/Head of CMC
WH
Wolf Hervé Fridman
Scientific Advisory Board Member
OH
Omid Hamid
Scientific Advisory Board Member
DJ
Dirk Jäger
Scientific Advisory Board Member